述评

乳腺外科数字化诊疗体系的构建与方向

  • 陈小松 ,
  • 沈坤炜
展开
  • 上海交通大学医学院附属瑞金医院普外科 乳腺疾病诊治中心, 上海 200025
作者贡献/Authors’ contributions

陈小松负责资料收集和撰写;沈坤炜负责指导、审查和修订。所有作者均阅读并确认最终稿。

沈坤炜,E-mail: kwshen@medmail.com.cn

收稿日期: 2026-05-25

  网络出版日期: 2026-08-11

Construction and direction of a digital diagnosis and treatment system in breast surgery

  • CHEN Xiaosong ,
  • SHEN Kunwei
Expand
  • Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2026-05-25

  Online published: 2026-08-11

摘要

乳腺外科诊疗从多学科管理,逐步迈向数字化、智能化与精准化。诊疗过程中产生的影像、病理、基因组学、临床治疗、随访及康复等多维数据,为构建全流程数字化诊疗体系提供了基础。依托人工智能(AI)、云平台、多模态影像融合及多组学整合技术,该体系可覆盖筛查诊断、治疗决策、手术规划、术后治疗及长期随访等环节,推动乳腺外科诊疗向数字化、智能化和精准化转型。

本文引用格式

陈小松 , 沈坤炜 . 乳腺外科数字化诊疗体系的构建与方向[J]. 外科理论与实践, 2026 , 31(03) : 183 -184 . DOI: 10.16139/j.1007-9610.2026.03.01

Abstract

Breast surgery diagnosis and treatment is gradually transitioning from multi-disciplinary management to digital, intelligent, and precision-based care. Multidimensional data generated during the diagnosis and treatment process—including imaging, pathology, genomics, clinical treatment, follow-up, and rehabilitation provides the foundation for a full-process digital diagnosis and treatment system. Supported by artificial intelligence (AI), cloud platforms, multimodal imaging fusion, and multi-omics integration, this system can cover screening, diagnosis, treatment decision-making, surgical planning, postoperative treatment, and long-term follow-up, thereby paving the way for the digital, intelligent, and precision-based transformation of breast surgery.

参考文献

[1] Eisemann N, Bunk S, Mukama T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening[J]. Nat Med, 2025, 31(3):917-924.
[2] Elías-Cabot E, Romero-Martín S, Raya-Povedano J L, et al. AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial[J]. Nat Med, 2026, 32(4):1296-1305.
[3] Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11(1):1236.
[4] Olawade D B, Oisakede E O, Bello O J, et al. Digital twins in oncology: from predictive modelling to personalised treatment strategies[J]. Crit Rev Oncol Hematol, 2026, 220:105171.
[5] Frenel J S, Heudel P E, Guinaudeau E, et al. Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer[J]. NPJ Digit Med, 2026,20.
文章导航

/

〈 〉